Zydus Lifesciences Future Growth
Future criteria checks 0/6
Zydus Lifesciences is forecast to grow earnings and revenue by 5% and 7.7% per annum respectively. EPS is expected to grow by 4.9% per annum. Return on equity is forecast to be 14.6% in 3 years.
Key information
5.0%
Earnings growth rate
4.9%
EPS growth rate
Pharmaceuticals earnings growth | 17.5% |
Revenue growth rate | 7.7% |
Future return on equity | 14.6% |
Analyst coverage | Good |
Last updated | 31 Jul 2024 |
Recent future growth updates
Recent updates
Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 03Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jul 19Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 05Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jun 20Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
May 25Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?
Mar 18Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%
Feb 28Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report
Feb 12Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors
Dec 06With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case
Aug 23Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
Jul 17We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's
Jun 24Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00
Jun 10Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
May 21Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Nov 13Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Shares Could Be 23% Below Their Intrinsic Value Estimate
Aug 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 243,156 | 41,752 | 39,159 | 50,580 | 10 |
3/31/2026 | 235,104 | 44,839 | 37,508 | 46,811 | 26 |
3/31/2025 | 219,372 | 42,911 | 33,438 | 42,449 | 28 |
3/31/2024 | 195,474 | 38,365 | 23,213 | 32,279 | N/A |
12/31/2023 | 190,241 | 29,562 | N/A | N/A | N/A |
9/30/2023 | 187,760 | 28,109 | 28,078 | 37,726 | N/A |
6/30/2023 | 184,127 | 25,262 | N/A | N/A | N/A |
3/31/2023 | 172,374 | 19,649 | 16,579 | 26,888 | N/A |
12/31/2022 | 164,335 | 20,785 | N/A | N/A | N/A |
9/30/2022 | 157,110 | 19,629 | 8,934 | 20,209 | N/A |
6/30/2022 | 153,361 | 21,710 | N/A | N/A | N/A |
3/31/2022 | 151,099 | 22,416 | 10,146 | 21,045 | N/A |
12/31/2021 | 157,609 | 23,267 | N/A | N/A | N/A |
9/30/2021 | 157,389 | 23,269 | 17,283 | 28,059 | N/A |
6/30/2021 | 156,130 | 22,600 | N/A | N/A | N/A |
3/31/2021 | 144,035 | 22,016 | 24,399 | 32,939 | N/A |
12/31/2020 | 150,076 | 18,465 | N/A | N/A | N/A |
9/30/2020 | 148,501 | 16,932 | 18,757 | 27,798 | N/A |
6/30/2020 | 143,967 | 13,270 | N/A | N/A | N/A |
3/31/2020 | 142,531 | 11,766 | 20,274 | 29,315 | N/A |
12/31/2019 | 142,338 | 12,448 | N/A | N/A | N/A |
9/30/2019 | 141,736 | 13,816 | 26,553 | 34,629 | N/A |
6/30/2019 | 137,682 | 16,919 | N/A | N/A | N/A |
3/31/2019 | 131,656 | 18,488 | 2,245 | 12,819 | N/A |
12/31/2018 | 126,706 | 19,954 | N/A | N/A | N/A |
9/30/2018 | 123,526 | 20,305 | N/A | N/A | N/A |
6/30/2018 | 126,133 | 21,168 | N/A | N/A | N/A |
3/31/2018 | 119,049 | 17,946 | -1,300 | 9,193 | N/A |
12/31/2017 | 111,691 | 15,705 | N/A | N/A | N/A |
9/30/2017 | 102,206 | 13,511 | N/A | N/A | N/A |
6/30/2017 | 93,397 | 12,277 | N/A | N/A | N/A |
3/31/2017 | 93,765 | 14,904 | N/A | 13,117 | N/A |
12/31/2016 | 97,494 | 11,323 | N/A | N/A | N/A |
9/30/2016 | 97,971 | 12,812 | N/A | N/A | N/A |
6/30/2016 | 97,221 | 14,186 | N/A | N/A | N/A |
3/31/2016 | 94,268 | 19,339 | N/A | 18,935 | N/A |
12/31/2015 | 95,901 | 14,843 | N/A | N/A | N/A |
9/30/2015 | 92,453 | 13,766 | N/A | N/A | N/A |
6/30/2015 | 89,795 | 12,638 | N/A | N/A | N/A |
3/31/2015 | 86,513 | 11,506 | N/A | 9,936 | N/A |
12/31/2014 | 82,955 | 10,394 | N/A | N/A | N/A |
9/30/2014 | 79,777 | 9,435 | N/A | N/A | N/A |
6/30/2014 | 76,165 | 8,488 | N/A | N/A | N/A |
3/31/2014 | 72,034 | 8,036 | N/A | 9,028 | N/A |
12/31/2013 | 68,204 | 8,266 | N/A | N/A | N/A |
9/30/2013 | 65,528 | 7,430 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZYDUSLIFE's forecast earnings growth (5% per year) is below the savings rate (6.7%).
Earnings vs Market: ZYDUSLIFE's earnings (5% per year) are forecast to grow slower than the Indian market (16.7% per year).
High Growth Earnings: ZYDUSLIFE's earnings are forecast to grow, but not significantly.
Revenue vs Market: ZYDUSLIFE's revenue (7.7% per year) is forecast to grow slower than the Indian market (9.8% per year).
High Growth Revenue: ZYDUSLIFE's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ZYDUSLIFE's Return on Equity is forecast to be low in 3 years time (14.6%).